Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Mollica

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Lancet (London, England)|December 17, 2023
Adjuvant treatment in renal cell carcinoma: a never-ending story?Veronica Mollica, Francesco Massari
Expert Opinion on Biological Therapy|September 9, 2022
Personalizing immunotherapy for renal cell carcinoma: how far have we come?Francesco Massari, Veronica Mollica
European Urology|July 7, 2020
Re: Platinum-based Chemotherapy in Metastatic Prostate Cancer with DNA Repair Gene AlterationsFrancesco Massari, Veronica Mollica
The Lancet. Oncology|April 3, 2023
Belzutifan: enhancing the blockade of angiogenesis in renal cell carcinomaVeronica Mollica, Francesco Massari
JAMA Oncology|May 13, 2021
Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate CancerAlessandro Rizzo, Veronica Mollica, Francesco Massari
European Urology Oncology|May 17, 2021
Re: Thomas Powles, Jonathan E. Rosenberg, Guru P. Sonpavde, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med 2021;384:1125-35Alessandro Rizzo, Veronica Mollica, Francesco Massari
JAMA Oncology|August 26, 2021
Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing IntegrityAlessandro Rizzo, Veronica Mollica, Francesco Massari
JAMA Oncology|March 3, 2022
Cabozantinib for Treatment of Brain Metastases in Patients With Renal Cell CarcinomaAlessandro Rizzo, Veronica Mollica, Francesco Massari
Minerva Urology and Nephrology|June 18, 2025
YAU-RCC Spotlight: can we train immunity to cure RCC? Lessons from a neoantigen vaccine trialVeronica Mollica, Riccardo Campi, Daniele Amparore, et al.
Nature Reviews. Urology|May 17, 2024
Overall survival with adjuvant pembrolizumab in renal cell carcinoma - the shock of the lightningFrancesco Massari, Matteo Rosellini, Veronica Mollica
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|December 17, 2023
Adjuvant treatment in renal cell carcinoma: a never-ending story?Veronica Mollica, Francesco Massari
Expert Opinion on Biological Therapy|September 9, 2022
Personalizing immunotherapy for renal cell carcinoma: how far have we come?Francesco Massari, Veronica Mollica
European Urology|July 7, 2020
Re: Platinum-based Chemotherapy in Metastatic Prostate Cancer with DNA Repair Gene AlterationsFrancesco Massari, Veronica Mollica
The Lancet. Oncology|April 3, 2023
Belzutifan: enhancing the blockade of angiogenesis in renal cell carcinomaVeronica Mollica, Francesco Massari
JAMA Oncology|May 13, 2021
Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate CancerAlessandro Rizzo, Veronica Mollica, Francesco Massari
European Urology Oncology|May 17, 2021
Re: Thomas Powles, Jonathan E. Rosenberg, Guru P. Sonpavde, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med 2021;384:1125-35Alessandro Rizzo, Veronica Mollica, Francesco Massari
JAMA Oncology|August 26, 2021
Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing IntegrityAlessandro Rizzo, Veronica Mollica, Francesco Massari
JAMA Oncology|March 3, 2022
Cabozantinib for Treatment of Brain Metastases in Patients With Renal Cell CarcinomaAlessandro Rizzo, Veronica Mollica, Francesco Massari
Minerva Urology and Nephrology|June 18, 2025
YAU-RCC Spotlight: can we train immunity to cure RCC? Lessons from a neoantigen vaccine trialVeronica Mollica, Riccardo Campi, Daniele Amparore, et al.
Nature Reviews. Urology|May 17, 2024
Overall survival with adjuvant pembrolizumab in renal cell carcinoma - the shock of the lightningFrancesco Massari, Matteo Rosellini, Veronica Mollica
Pageof 24